Abstract:"Resveratrol has differential effects on neuronal and glial MMP release" As shown above, resveratrol inhibits basal and LPS‐stimulated release of MMP2/9 from cultured glia, which may promote BBB injury, but spares basal and NMDA‐stimulated MMP‐9 release from neurons, which may promote neuronal plasticity. Of interest, however, resveratrol reduces PNN component expression from both culture types. Resveratrol, a naturally occurring polyphenol that activates sirtuin 1 (SIRT1), has been shown to reduce overall levels of matrix metalloprotease‐9 (MMP‐9) in cerebrospinal fluid (CSF) samples from patients with Alzheimer's dementia (AD). Depending on the site of release, however, MMP‐9 has the potential to improve or impair cognition. In particular, its release from microglia or pericytes proximal to the blood brain barrier can damage the basement membrane, while neuronal activity‐dependent release of this protease from glutamatergic neurons can instead promote dendritic spine expansion and long‐term potentiation of synaptic plasticity. In the present study, we test the hypothesis that resveratrol reduces overall MMP‐9 levels in CSF samples from patients with APOE4, an allele associated with increased glial inflammation. We also examine the possibility that resveratrol reduces inflammation‐associated MMP release from cultured glia but spares neuronal activity‐dependent release from cultured cortical neurons. We observe that resveratrol decreases overall levels of MMP‐2 and MMP‐9 in CSF samples from AD patients. Resveratrol also reduces CSF levels of tissue inhibitor of metalloproteinases‐1 (TIMP‐1), glial‐derived protein that restricts long‐term potentiation of synaptic transmission, in individuals homozygous for APOE4. Consistent with these results, we observe that resveratrol reduces basal and lipopolysaccharide (LPS)‐stimulated MMP and TIMP‐1 release from cultured microglia and astrocytes. In contrast, however, resveratrol does not inhibit release of MMP‐9 from cortical neurons. Overall, these results are consistent with the possibility that while resveratrol reduces potentially maladaptive MMP and TIMP‐1 release from activated glia, neuroplasticity‐promoting MMP release from neurons is spared. In contrast, resveratrol reduces release of neurocan and brevican, extracellular matrix components that restrict neuroplasticity, from both neurons and glia. These data underscore the diversity of resveratrol's actions with respect to affected cell types and molecular targets and also suggest that further studies may be warranted to determine if its effects on glial MMP release could make it a useful adjunct for AD‐ and/or anti‐amyloid therapy‐related damage to the blood brain barrier.

Resveratrol Inhibits MMP-9 Expression by Up-Regulating PPAR Α Expression in an Oxygen Glucose Deprivation-Exposed Neuron Model

The mechanism of inhibitive effect of resveratrol on matrix metalloproteinase-9 in neuron

Resveratrol Inhibits Macrophage Expression of EMMPRIN by Activating PPARγ

Resveratrol regulates skeletal muscle fibers switching through the AdipoR1-AMPK-PGC-1α pathway.

Resveratrol Inhibits Expression of EMMPRIN from Macrophages

Resveratrol inhibits oxygen-glucose deprivation-induced MMP-3 expression and cell apoptosis in primary cortical cells via the NF-κB pathway.

Resveratrol Protects Primary Cortical Neuron Cultures From Transient Oxygen-Glucose Deprivation By Inhibiting Mmp-9

Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs

Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice.

Resveratrol differentially affects MMP‐9 release from neurons and glia; implications for therapeutic efficacy

Resveratrol Attenuates the Blood-Brain Barrier Dysfunction by Regulation of the MMP-9/TIMP-1 Balance after Cerebral Ischemia Reperfusion in Rats

Resveratrol attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation

[Effects of Resveratrol on Aging of Mesenchymal Stem Cells and Its Mechanism].

Resveratrol promotes osteogenesis and alleviates osteoporosis by inhibiting p53

Resveratrol Inhibits Inflammatory Responses Via The Mammalian Target Of Rapamycin Signaling Pathway In Cultured Lps-Stimulated Microglial Cells

Protective effects of resveratrol against neuronal injury induced by instant OGD in vitro

Resveratrol Alleviates Oxygen/glucose Deprivation/reoxygenation‑induced Neuronal Damage Through Induction of Mitophagy.

Trans-Resveratrol Attenuates High Fatty Acid-Induced P2X7 Receptor Expression and IL-6 Release in PC12 Cells: Possible Role of P38 MAPK Pathway

Effect of resveratrol on marix metalloproteinase 9 (MMP-9) induced by cerebral ischemia-reperfusion in mice

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.

Resveratrol Inhibits Zinc Deficiency-Induced Mitophagy and Exerts Cardiac Cytoprotective Effects